To explore the increased frequency of dry eye syndrome in patients who have undergone both refractive surgery and blepharoplasty.

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900028615

Enrollment

Unknown

Registered

2019-12-29

Start date

2020-01-01

Completion date

Unknown

Last updated

2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye

Interventions

Blepharoplasty:Blepharoplasty

Control group:None

Eligibility

Sex/Gender

Female

Age

18 Years to 30 Years

Inclusion criteria

Inclusion criteria: Dry eye, Blepharoplasty, Refractive surgery.

Exclusion criteria

Exclusion criteria: Patients with severe hypertension, diabetes mellitus, heart, lung, renal insufficiency and thyroid diseases; patients with rheumatoid arthritis, gout, Stevens-Johnson syndrome, Sj?gren disease, systemic lupus erythematosus, multiple sclerosis, etc.; patients with eye trauma, entropion or ectropion, uveitis, glaucoma, fundus ocular disease, and other eye diseases.

Design outcomes

Primary

Measure	Time frame
ocular surface disease index (OSDI);corneal fluorescein;tear meniscus height (TMH);Sehirmer I;TBUT;	—

Countries

China

Contacts

Public ContactLong Keli

Shandong Eye Instiute, Qingdao Eye Hospital

longkeli2002@aliyun.com+86 18363923979

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026